Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury

被引:116
作者
Burne-Taney, MJ
Kofler, J
Yokota, N
Weisfeldt, M
Traystman, RJ
Rabb, H
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA
关键词
lymphocytes; cardiac arrest; kidney dysfunction;
D O I
10.1152/ajprenal.00026.2003
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Acute renal failure (ARF) commonly occurs after whole body ischemia. Most experimental models of ARF have relied on the isolated renal artery clamping model; however, there is a pressing need to develop and understand the pathogenesis of new models with more "clinical relevance." We evaluated a new murine model of ARF after whole body ischemia reperfusion injury (WBIRI). WBIRI was induced by an infusion of potassium chloride and a cardiac arrest period of 10 min. Resuscitation was achieved by cardiac compressions, ventilation, epinephrine, and fluids. WBIRI leads to a significant increase in serum creatinine (SCr) and renal tubular injury by 24 h. Renal myeloperoxidase (MPO) levels increased at 24 h after WBIRI. Increased expression of the proinflammatory genes, ICAM-1 and IL-6, was also observed in the kidney following WBIRI. On the basis of recent data that T cells are important mediators of isolated renal IRI, WBIRI was evaluated in T cell-deficient nu/nu mice. T cell-deficient mice had a significantly reduced rise in SCr and decreased tubular injury compared with wild-type mice. T cell-deficient mice had a decrease in ICAM-1 expression after WBIRI, but no decrease in renal MPO. This study describes a new, clinically relevant, model of ARF after WBIRI in mice and identifies the T cell as an important mediator of renal injury following WBIRI. Reduced ICAM-1 expression may provide a mechanism for this involvement.
引用
收藏
页码:F87 / F94
页数:8
相关论文
共 43 条
  • [11] Alterations of soluble L- and P-selectins during cardiac arrest and CPR
    Gando, S
    Nanzaki, S
    Morimoto, Y
    Kobayashi, S
    Kemmotsu, O
    [J]. INTENSIVE CARE MEDICINE, 1999, 25 (06) : 588 - 593
  • [12] Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat
    Haller, H
    Dragun, D
    Miethke, A
    Park, JK
    Weis, A
    Lippoldt, A
    Gross, V
    Luft, FC
    [J]. KIDNEY INTERNATIONAL, 1996, 50 (02) : 473 - 480
  • [13] Haq M, 1998, J AM SOC NEPHROL, V9, P614
  • [14] Horie Y, 1997, J IMMUNOL, V159, P5053
  • [15] Utstein-Style Guidelines for Uniform Reporting of Laboratory CPR Research - A statement for healthcare professionals from a task force of the American Heart Association, the American College of Emergency Physicians, the American College of Cardiology, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, the Institute of Critical Care Medicine, the Safar Center for Resuscitation Research, and the Society for Academic Emergency Medicine
    Idris, AH
    Becker, LB
    Ornato, JP
    Hedges, JR
    Bircher, NG
    Chandra, NC
    Cummins, RO
    Dick, W
    Ebmeyer, U
    Halperin, HR
    Hazinski, MF
    Kerber, RE
    Kern, KB
    Safar, P
    Steen, PA
    Swindle, MM
    Tsitlik, JE
    vonPlanta, I
    vonPlanta, M
    Wears, RL
    Weil, MH
    [J]. CIRCULATION, 1996, 94 (09) : 2324 - 2336
  • [16] DIFFERING REGULATION AND FUNCTION OF ICAM-1 AND CLASS-II ANTIGENS ON RENAL TUBULAR CELLS
    JEVNIKAR, AM
    WUTHRICH, RP
    TAKEI, F
    XU, HW
    BRENNAN, DC
    GLIMCHER, LH
    RUBINKELLEY, VE
    [J]. KIDNEY INTERNATIONAL, 1990, 38 (03) : 417 - 425
  • [17] LEUKOCYTE-FUNCTION-ASSOCIATED-ANTIGEN-1 (LFA-1) AND CD44 ARE SIGNALING MOLECULES FOR CYTOSKELETON-DEPENDENT MORPHOLOGICAL-CHANGES IN ACTIVATED T-CELLS
    KELLEHER, D
    MURPHY, A
    FEIGHERY, C
    CASEY, EB
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 58 (05) : 539 - 546
  • [18] Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury
    Kelly, KJ
    Williams, WW
    Colvin, RB
    Meehan, SM
    Springer, TA
    GutierrezRamos, JC
    Bonventre, JV
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (04) : 1056 - 1063
  • [19] KELLY KJ, 1995, ACUTE RENAL FAILURE, P401
  • [20] KOFLER J, 2003, IN PRESS PHARM CEREB